Table 6.
Vaccines under development using various components of SARS-CoV-2 [205].
| Viral Product used in pre-clinical vaccine trials |
Developer | |
|---|---|---|
| DNA | Inovio pharmaceuticals takis/ Applied DNA sciences Evvivax Zydus Cadila | |
| Inactivated viral products | Sinovac Codagenix / Serum Institute of India | |
| Non replicating viral vector | GeoVax/BravoVax Greffex University of Oxford Altimmune Vaxact Janssen Pharmaceutical companies | |
| Viral protein subunit | ExpreS2ion WRAIR/USAMRIID Clover Biopharmaceuticals Inc/GSK Vaxil Bio AJ Vaccines / EpiVax EpiVax/ Uni of Georgia Sanof Pasteur Novavax Heat Biologics / University of Miami University of Queensland / GSK Baylor college of Medicine Bio/CC-Pharming VIDO-InterVac University of Saskatchewan |
|
| RNA | Fudan University/ Shanghai JiaoTong University RNACure Biopharma China CDC/Tongji University/ Stermina Moderna/ NIAD Arcturus/ Duke-NUS Imperial College London CureVac BioNTech/Fosun Pharma/ pfizerBIOCAD Sanofi Pasteur / Translate Bio | |